SRGAP2B
gene geneOn this page
Summary
SRGAP2B (SLIT-ROBO Rho GTPase activating protein 2B, HGNC:35237) is a protein-coding gene on chromosome 1q21.1, encoding SLIT-ROBO Rho GTPase-activating protein 2B (P0DMP2). May regulate cell migration and differentiation through interaction with and inhibition of SRGAP2.
This locus encodes a member of the SLIT-ROBO Rho GTPase activating protein family. This human-specific locus resulted from incomplete segmental duplication of the SLIT-ROBO Rho GTPase activating protein 2 locus. The encoded protein lacks the GTPase activating protein domain compared to proteins encoded by SLIT-ROBO Rho GTPase activating protein 2. The functionality of the protein encoded by this locus has been questioned, as several normal individuals with homozygous deletions for this locus have been identified, and the expression of this locus appears to be much lower than the similar SLIT-ROBO Rho GTPase activating protein 2C (SRGAP2C) locus. The SRGAP2C locus has been shown to encode a protein that functions antagonistically to SLIT-ROBO Rho GTPase activating protein 2 in cortical neuron development.
Source: NCBI Gene 647135 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001271870
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:35237 |
| Approved symbol | SRGAP2B |
| Name | SLIT-ROBO Rho GTPase activating protein 2B |
| Location | 1q21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000196369 |
| Ensembl biotype | protein_coding |
| OMIM | 614703 |
| Entrez | 647135 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 5 protein_coding, 3 protein_coding_CDS_not_defined, 2 nonsense_mediated_decay
ENST00000463366, ENST00000467933, ENST00000494534, ENST00000612199, ENST00000619678, ENST00000621582, ENST00000641863, ENST00000921139, ENST00000921140, ENST00000921141
RefSeq mRNA: 7 — MANE Select: NM_001271870
NM_001271870, NM_001330684, NM_001366280, NM_001368324, NM_001385226, NM_001385227, NM_001385228
CCDS: CCDS72854, CCDS91032
Canonical transcript exons
ENST00000641863 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001848190 | 145092835 | 145093443 |
| ENSE00001896467 | 144995008 | 144995200 |
| ENSE00001933449 | 144955439 | 144955601 |
| ENSE00003712932 | 144914692 | 144914754 |
| ENSE00003727436 | 144905859 | 144906074 |
| ENSE00003733510 | 144905091 | 144905219 |
| ENSE00003746592 | 144893408 | 144893509 |
| ENSE00003812510 | 144887288 | 144892381 |
| ENSE00003813658 | 144897116 | 144897340 |
| ENSE00003923687 | 145095223 | 145095328 |
Expression profiles
Bgee: expression breadth ubiquitous, 137 present calls, max score 99.60.
Top tissues by expression
137 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cerebellar vermis | UBERON:0004720 | 99.60 | gold quality |
| sural nerve | UBERON:0015488 | 96.14 | gold quality |
| cerebellum | UBERON:0002037 | 95.14 | gold quality |
| cerebellar cortex | UBERON:0002129 | 95.12 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 95.04 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 94.08 | gold quality |
| thymus | UBERON:0002370 | 93.63 | gold quality |
| ventricular zone | UBERON:0003053 | 90.71 | gold quality |
| adrenal tissue | UBERON:0018303 | 88.96 | gold quality |
| stromal cell of endometrium | CL:0002255 | 87.97 | gold quality |
| ganglionic eminence | UBERON:0004023 | 86.76 | gold quality |
| cortical plate | UBERON:0005343 | 85.63 | gold quality |
| tibial nerve | UBERON:0001323 | 85.38 | gold quality |
| spinal cord | UBERON:0002240 | 85.33 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 85.29 | gold quality |
| skin of leg | UBERON:0001511 | 85.17 | gold quality |
| calcaneal tendon | UBERON:0003701 | 84.86 | gold quality |
| zone of skin | UBERON:0000014 | 84.77 | gold quality |
| monocyte | CL:0000576 | 84.41 | gold quality |
| right lung | UBERON:0002167 | 84.31 | gold quality |
| skin of abdomen | UBERON:0001416 | 83.94 | gold quality |
| leukocyte | CL:0000738 | 83.85 | gold quality |
| placenta | UBERON:0001987 | 83.49 | gold quality |
| prefrontal cortex | UBERON:0000451 | 83.04 | gold quality |
| bone marrow cell | CL:0002092 | 82.96 | gold quality |
| gall bladder | UBERON:0002110 | 82.43 | gold quality |
| bone marrow | UBERON:0002371 | 82.37 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 82.17 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 81.79 | gold quality |
| Ammon’s horn | UBERON:0001954 | 81.68 | gold quality |
Single-cell (SCXA)
Detected in 7 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-35 | yes | 47.43 |
| E-CURD-119 | yes | 32.42 |
| E-HCAD-25 | yes | 24.09 |
| E-ANND-3 | yes | 8.00 |
| E-MTAB-7381 | no | 230.38 |
| E-MTAB-6819 | no | 210.95 |
| E-MTAB-6524 | no | 70.97 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
186 targeting SRGAP2B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-6740-5P | 100.00 | 65.64 | 932 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-6793-5P | 99.97 | 65.95 | 758 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | srgap2 | ENSDARG00000032161 |
| mus_musculus | Srgap2 | ENSMUSG00000026425 |
| rattus_norvegicus | Srgap2 | ENSRNOG00000006733 |
| caenorhabditis_elegans | WBGENE00006406 |
Paralogs (5): ARHGAP4 (ENSG00000089820), SRGAP2C (ENSG00000171943), SRGAP3 (ENSG00000196220), SRGAP1 (ENSG00000196935), SRGAP2 (ENSG00000266028)
Protein
Protein identifiers
SLIT-ROBO Rho GTPase-activating protein 2B — P0DMP2 (reviewed: P0DMP2)
Alternative names: SLIT-ROBO Rho GTPase activating protein 2 pseudogene 2
All UniProt accessions (4): P0DMP2, A0A087WW56, A0A087X1G6, A0A286YEY3
UniProt curated annotations — full annotation on UniProt →
Function. May regulate cell migration and differentiation through interaction with and inhibition of SRGAP2. In contrast to SRGAP2C, it is not able to induce long-lasting changes in synaptic density throughout adulthood.
Subunit / interactions. May interact with SRGAP2; formation of the heterodimer alters SRGAP2 function.
Miscellaneous. This is one of the 3 duplications of the ancestral gene SRGAP2/SRGAP2A which has undergone human-specific segmental gene duplications. The appearance of SRGAP2B in the human genome is estimated to 3,4 million years. Two larger duplications later copied SRGAP2B to chromosome 1p12 (SRGAP2C) and to proximal 1q21.1 (SRGAP2D). SRGAP2B was identified in some individuals but it is not clear if it produces a functional protein.
RefSeq proteins (7): NP_001258799, NP_001317613, NP_001353209, NP_001355253, NP_001372155, NP_001372156, NP_001372157 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001060 | FCH_dom | Domain |
| IPR027267 | AH/BAR_dom_sf | Homologous_superfamily |
| IPR031160 | F_BAR_dom | Domain |
| IPR051627 | SLIT-ROBO_RhoGAP | Family |
Pfam: PF00611
UniProt features (5 total): chain 1, domain 1, region of interest 1, coiled-coil region 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0DMP2-F1 | 88.76 | 0.76 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 71 (showing top):
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, GOBP_SYNAPSE_ASSEMBLY, GOBP_REGULATION_OF_CELL_JUNCTION_ASSEMBLY, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, GOBP_CELL_JUNCTION_ORGANIZATION, GOBP_REGULATION_OF_SYNAPSE_ASSEMBLY, GOBP_REGULATION_OF_SYNAPSE_STRUCTURE_OR_ACTIVITY, GOBP_CELL_JUNCTION_ASSEMBLY, GOCC_NEURON_PROJECTION, chr1q21, GOCC_POSTSYNAPSE, GOCC_NEURON_SPINE, GOCC_SYNAPSE, GOCC_SOMATODENDRITIC_COMPARTMENT
GO Biological Process (3): nervous system development (GO:0007399), negative regulation of cell migration (GO:0030336), regulation of synapse assembly (GO:0051963)
GO Molecular Function (2): GTPase activator activity (GO:0005096), protein binding (GO:0005515)
GO Cellular Component (2): dendritic spine (GO:0043197), glutamatergic synapse (GO:0098978)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| system development | 1 |
| cell migration | 1 |
| regulation of cell migration | 1 |
| negative regulation of cell motility | 1 |
| synapse assembly | 1 |
| regulation of synapse organization | 1 |
| regulation of cell junction assembly | 1 |
| GTPase activity | 1 |
| enzyme activator activity | 1 |
| GTPase regulator activity | 1 |
| binding | 1 |
| dendrite | 1 |
| neuron spine | 1 |
| postsynapse | 1 |
| synapse | 1 |
Protein interactions and networks
STRING
174 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SRGAP2B | FAM72D | Q6L9T8 | 691 |
| SRGAP2B | FAM72C | H0Y354 | 590 |
| SRGAP2B | FAM72B | Q86X60 | 589 |
| SRGAP2B | ARHGAP11B | Q3KRB8 | 575 |
| SRGAP2B | FAM72A | Q5TYM5 | 411 |
| SRGAP2B | GTF2IRD2 | Q86UP8 | 370 |
| SRGAP2B | GTF2IRD2B | Q6EKJ0 | 370 |
| SRGAP2B | NOTCH2NLB | P0DPK3 | 353 |
| SRGAP2B | NBPF15 | Q8N660 | 350 |
| SRGAP2B | NOTCH2NLA | Q7Z3S9 | 348 |
| SRGAP2B | ARHGAP11A | Q6P4F7 | 339 |
| SRGAP2B | KCTD19 | Q17RG1 | 338 |
| SRGAP2B | NBPF14 | Q5TI25 | 324 |
| SRGAP2B | IGHV3-11 | P01762 | 296 |
| SRGAP2B | CFAP46 | Q8IYW2 | 290 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CALD1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (9): SRGAP2B (Affinity Capture-RNA), SRGAP2B (Two-hybrid), SRGAP2B (Two-hybrid), SRGAP2B (Two-hybrid), SRGAP2B (Two-hybrid), SRGAP2B (Two-hybrid), SRGAP2B (Two-hybrid), ZNF655 (Two-hybrid), SRGAP2B (Affinity Capture-MS)
ESM2 similar proteins: A1XBS5, B0S6J3, D4A208, O35180, O35964, O43295, O75044, P0DJJ0, P0DMP2, P25343, Q08DK5, Q15057, Q1LU86, Q1RMK1, Q2VR06, Q32LM0, Q3SZG6, Q3V2J0, Q5AFE4, Q5FVC7, Q5PPJ9, Q5PPZ5, Q5R8P5, Q5ZIR1, Q5ZJ81, Q5ZK62, Q62419, Q62421, Q68FW8, Q6AYE2, Q6GN09, Q6IVG4, Q6ZQK5, Q6ZTR7, Q7Z6B7, Q812A2, Q8AXU9, Q8BP22, Q8I190, Q8I1C0
Diamond homologs: A0JNB0, A1A5H8, A1Y2K1, A7A261, B0S6J3, B1V8A0, D4A208, F1LM93, F1LXF1, F1RDG9, O35413, O43295, O75044, O94875, P00523, P00525, P05480, P06241, P07947, P09324, P09769, P0DJJ0, P0DMP2, P10936, P11274, P12931, P13115, P13116, P13406, P14084, P14085, P15054, P15882, P19706, P27446, P27447, P30337, P32793, P39688, P42686
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
3089 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:144905173:C:G | R250P | 1.000 |
| 1:144905218:C:G | R235P | 1.000 |
| 1:144906019:A:G | L181P | 1.000 |
| 1:144905147:C:G | A259P | 0.999 |
| 1:144905158:A:G | L255P | 0.999 |
| 1:144905165:A:C | Y253D | 0.999 |
| 1:144905176:G:T | A249D | 0.999 |
| 1:144905177:C:G | A249P | 0.999 |
| 1:144905208:C:A | K238N | 0.999 |
| 1:144905208:C:G | K238N | 0.999 |
| 1:144905210:T:C | K238E | 0.999 |
| 1:144905219:G:T | R235S | 0.999 |
| 1:144906011:C:G | A184P | 0.999 |
| 1:144906023:T:C | K180E | 0.999 |
| 1:144906032:C:G | A177P | 0.999 |
| 1:144906062:A:C | Y167D | 0.999 |
| 1:144914699:A:G | L160P | 0.999 |
| 1:144995122:A:G | L49P | 0.999 |
| 1:144995185:A:G | L28P | 0.999 |
| 1:144897279:G:T | A297D | 0.998 |
| 1:144897280:C:G | A297P | 0.998 |
| 1:144897309:A:G | L287P | 0.998 |
| 1:144905165:A:G | Y253H | 0.998 |
| 1:144905186:C:G | A246P | 0.998 |
| 1:144905859:C:A | K234N | 0.998 |
| 1:144905859:C:G | K234N | 0.998 |
| 1:144905861:T:C | K234E | 0.998 |
| 1:144906021:T:A | K180N | 0.998 |
| 1:144906021:T:G | K180N | 0.998 |
| 1:144995068:A:G | L67P | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000594 (1:145060130 A>T), RS1003350 (1:145058288 C>T), RS10127826 (1:145031191 G>A), RS10158906 (1:144959963 C>G,T), RS10159125 (1:145075641 A>T), RS10159129 (1:145075715 A>G,T), RS10217823 (1:145080911 A>G), RS10217824 (1:145080974 A>G), RS10217828 (1:145080910 T>A), RS1028475 (1:145026668 T>C), RS1028476 (1:145026833 C>T), RS10399870 (1:145033419 G>C), RS1040627 (1:144995771 C>A,T), RS1040628 (1:144995885 C>T), RS1040629 (1:144996128 C>T)
Disease associations
OMIM: gene MIM:614703 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium Chloride | decreases expression, increases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | affects expression | 1 |
| arsenite | affects binding, decreases reaction | 1 |
| sodium arsenite | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| Leflunomide | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Doxorubicin | decreases expression | 1 |
| Paraoxon | decreases expression | 1 |
| Smoke | decreases expression, increases abundance | 1 |
| Valproic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.